Eyecelerator @ ARVO 2026 

Registration and breakfast

​

Location: Bluebird Ballroom, 4th Level​​

Welcome and Overview of Eyecelerator @ ARVO 2026​​​​

​

​​​Moderators:

• Gil Kliman, MD, MBA, Program Director

​

​Speakers: ​

​

Capital Market Overview

• Andrew Gitkin, Managing Partner, Gitkin & Co.

​

VC Market Overview

• Garrett Hamontree, MBA, Partner, Visionary Ventures

​

Ophthalmology Market Overview

• Sergio Rossi, Senior Partner & Managing Director, Boston Consulting Group

​

​Panel: 

• Andrew Gitkin, Managing Partner, Gitkin & Co

• Adrienne Graves, PhD, Board Chair, Foundation Fighting Blindness RD fund

• Garrett Hamontree, Partner, Visionary Ventures

• Kelly Giuffrida, Vice President, Eye Care, AbbVie

• Sergio Rossi, Senior Partner & Managing Director, Boston Consulting Group

​​​Moderators: 

• Raj Rajpal, MD, Chief Strategy and Medical Officer, Horizon Surgical Systems

• Julie Schallhorn, MD, MS, Program Co-Chair

​
Panel: 

• Daniela Ferrara, MD, PhD, Chief Medical Officer, Topcon Healthcare

• Sujay Jadhav, MBA, CEO, Verana Health

• Nick Pennington, CEO, Ufonia

• Roshni Bhagalia, PhD, VP-Digital Products, Surgical, Alcon 

Networking Break 

​Moderators: 

• Robert L. Avery, MD, Program Co-Chair

• Ross Ethier, PhD, Program Committee

​​

​Speakers: 

Overview of Drug Delivery

• Uday Kompella, PhD, Founder, Ocugen

​​​

​Panel: 

• Jay S. Duker, MD, President & CEO, EyePoint

• Beth Marsh, Chief Commercial Officer, Neurotech

• Tomas Navratil, PhD, Chief Development Officer, Glaukos

• Michael J. O’Rourke, CEO, Re-Vana Therapeutics

• Austin Blackwell, Head of Marketing, Retina, AbbVie

​Moderators: 

• Stephen McLeod, MD, Program Committee

• Gil Kliman, MD, Program Director

​​​

Panel:

• Doug Fisher, MD, Partner, Revelation Partners

• Mike Papac, PhD

• Firas Rahhal, MD, Partner, ExSight Ventures 

• Namrata Saroj, OD, Chief Business Officer, Ocular Therapeutics

• Rob Scott, PhD, Vice President, Intraocular Devices R & D, Alcon

• Christine Winoto, MBA, Founding Partner, MedTech Venture Partners

• Gali Baler, PhD, Managing Director, Strategy and Operations, CU Innovations

​​Moderators: 

• Allen C. Ho, MD, Retina Program Director

• Srinivas Sadda, MD, Program Committee

​​​

Panelists:

• Kapil Bharti, PhD, NIH Senior Investigator

• Mark Humayun, MD, PhD, Director, USC Ginsburg Institute for Biomedical Therapeutics 

• Henry Wiley, MD, Lead Medical Director, Genentech

• Peter Francis, MD, PhD, Chief Scientific and Medical Officer, Ray Technologies

• Samarendra Mohanty, President & Co-Founder, Nanoscope Therapeutics 

• Ralf Hornig, PhD, Director, Clinical Affairs, Science Corporation

Enjoy a bite with your colleagues.​​

Forty companies will present innovative new treatments, products, and services. Three breakout rooms will operate simultaneously for each segment. Links for showcase schedules will be updated below:

​

Anterior Segment / Glaucoma -  Room: 401, Level 3

Moderators:

• Julie M. Schallhorn, MD, MS, Program Committee 

• Kuldev Singh, MD, MPH, Program Co-Chair

• ​

Durable Retina Therapeutics: Gene Therapy and Drug Delivery - Room: 403, Level 3

Moderators:

• Robert L. Avery, MD, Program Co-Chair

• Lejla Vajzovic, MD

​​

Next Generation Retina Therapeutics and Advances in AI - Room: 405, Level 3

Moderators:

• Allen C. Ho, MD, Retina Program Director

• Srinivas Sadda, MD, Program Committee

​

​

​

Networking Break ​

​​Moderators:

• Kuldev Singh, MD, MPH, Program Co-Chair

• Robert L. Avery, MD, Program Co-Chair

• Allen C. Ho, MD, Retina Program Director

​​

Panel:

​​

• Heidi Becker, MD, CDER

​​Moderators:

• Kuldev Singh, MD, MPH, Program Co-Chair

• Robert L. Avery, MD, Program Co-Chair

• Allen C. Ho, MD, Retina Program Director

Panel:

​​

• Pravin Dugel, MD, President & CEO, Ocular Therapeutix

• Jeffry Weinhuff, Managing Partner, Visionary Ventures

The program committee wraps the day with the People's Choice recognition of best presenting company by segment.  

​

Enjoy refreshments and connect!